E-viri
Recenzirano
-
Wagner, Stephan N; Rebmann, Vera; Willers, Christoph P; Grosse-Wilde, Hans; Goos, Manfred
The Lancet (British edition), 07/2000, Letnik: 356, Številka: 9225Journal Article
Individual predictive clinical, immunological, or molecular features for definition of patients with lymph-node-positive melanoma who do not benefit from adjuvant postsurgery high-dose interferon alfa treatment are lacking. Expression analysis of classic and non-classic HLA molecules on melanoma cells metastatic to the locoregional lymph node may help select these patients before treatment.
